While medical cannabis has been legal in the country since 2016, the new study found that over 85% of the total prescriptions given to date have only been issued since January 2020.
Many patients with rheumatic disease pain are aware of the benefits of cannabis-based treatments, but research is lagging behind them.
Frequent cannabis users are more likely to have a premature heart attack –a heart attack before the age of 50 – than non-users, according to new research from scientists at Stanford University.
According to the administration, the products were illegally marketed as unapproved treatments for various medical conditions.
The number of cannabis poisoning cases reported in Canadian pets has increased significantly since 2018, according to a new study from researchers at the University of Guelph, Ontario.
More than half of hemp-based delta-9 THC products vary substantially from the doses on their labels, new testing has found.
The researchers found that when states legalized cannabis, the volume of prescriptions given out for drugs related to managing pain, depression, anxiety, sleep, psychosis, and seizures all decreased significantly.
Given that some of marijuana's benefits remained past the six- or twelve-month mark, the review authors recommend that more long-term studies be done on medicinal cannabis formulations for MS.